FP5Training site2001–2005
Functional genomics of p21-activated protein kinases
FP5 — Improving Human Research Potential
- Duration
- 2001-11-01 → 2005-10-31
- EU contribution
- €235,200
- Participants
- 1
- Scheme
- BUR
Lines connect the coordinator with its partners.
Participants
- AVENTIS PHARMA DEUTSCHLAND GMBH · FRANKFURT AM-MAINCoordinatorGermany
Links
Data: CORDIS, © European Union